# US 2021/0276953 A1 · Phthalide derivative, preparation method and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0276953 A1
- Document ID: US20210276953A1
- Status: Published application
- Kind: A1
- Application number: 17/257,736
- Filed: 2019-01-17
- Published: 2021-09-09
- Earliest claimed: 2018-07-05
- Assignees: Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences
- Applicants: Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences
- Inventors: Junxi LIU; Yaming ZHANG
- Web page: https://patentgrep.com/patent/US20210276953A1

## CPC

- C07D 209/48: with oxygen atoms in positions 1 and 3, e.g. phthalimide
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 39/06: Free radical scavengers or antioxidants
- C07B 2200/07: Optical isomers
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention discloses a phthalide derivative, the structure of said derivative is represented by Formula (I) or Formula (II). The present invention also discloses the preparation method and use of said derivative. The phthalide compound obtained through structure modifications in the present invention enhances the chemical stability and pharmacological activity of the phthalide compound, facilitating the improvement of the druggability of such compounds.

## Claims

### Claim 1

A phthalide derivative of Formula I or Formula II, an optical isomer or pharmaceutically acceptable salt thereof, or their mixtures

### Claim 2 (depends on 1)

The phthalide derivative according to claim 1, which is N-cyclopropyl-3-n-butyl-3-S-hydroxy-ligusticum lactam, N-cyclopropyl-3-n-butyl-3-R-hydroxy-ligusticum lactam, N-cyclopropyl-3-n-butyl-3-S-hydroxy-phthalide lactam, or N-cyclopropyl-3-n-butyl-3-R-hydroxy-phthalide lactam.

### Claim 3

A method for preparing a phthalide derivative, comprising reacting a phthalide compound with cyclopropylamine in an organic solvent, wherein the original lactone structure fragment in the phthalide compound is replaced by a lactam group and the C3-position is substituted by hydroxyl group.

### Claim 4 (depends on 3)

The method according to claim 3, wherein
1) the phthalide compound is a benzene ring type, a dihydrobenzene ring type, or a tetrahydrobenzene ring type of phthalide compound with n-butenyl substitution at C3-position, preferably ligustilide or n-butenylphthalide, wherein the ligustilide or n-butenylphthalide is in the form of individually separate compound or in the form of a mixture of Angelica or Ligusticum plant extract, more preferably the plant extract is Angelica sinensis volatile oil extract or Ligusticum wallichii volatile oil extract or a mixture thereof;
2) the reaction is carried out at −20° C. to 60° C., and preferably carried out under stirring;
3) the organic solvent is a nonpolar organic solvent, preferably selected from cyclohexane, petroleum ether, tetrahydrofuran, and diethyl ether; and/or
4) the method also comprises a step of chiral resolution of enantiomers, preferably by chiral chromatography or chiral recrystallization.

### Claim 5 (depends on 3)

The method according to claim 3, wherein the molar ratio of the phthalide compound to cyclopropylamine is from 1:1 to 1.2.

### Claim 6 (depends on 3)

The method according to claim 3, further comprising a step of recycling the organic solvent under reduced pressure and recrystallizing to obtain the target product, wherein preferably the solvent used for the recrystallization is one or two of petroleum ether, ethyl acetate, acetone, and diethyl ether.

### Claim 7 (depends on 3)

The method according to claim 3, comprising adding and dissolving the phthalide compound in the organic solvent, with the temperature controlled at −20° C. to 60° C., and adding a reaction solution of cyclopropylamine dissolved in an organic solvent, with the temperature controlled at −20° C. to 60° C., stirring and reacting for 1-24 hours, recycling the organic solvent under reduced pressure, and recrystallizing to obtain the target product.

### Claim 8 (depends on 3)

A phthalide derivative, prepared by the method according to claim 3, an optical isomer or pharmaceutically acceptable salt thereof, or their mixtures.

### Claim 9 (depends on 1)

A method of anti-oxidation and/or treatment or prevention the following diseases: cardiovascular and cerebrovascular diseases, depression, Alzheimer's disease, (neuro-)inflammatory diseases, pain, neuronal cell damage, ischemia-reperfusion injury, cerebral infarction, cognitive impairment, or brain damage, comprising administering a therapeutically effective amount of the phthalide derivative of Formula I or Formula II according to claim 1, an optical isomer or pharmaceutically acceptable salt thereof, or their mixtures to a subject in need of the anti-oxidation and/or treatment or prevention.

### Claim 10 (depends on 9)

The method according to claim 9, wherein a mixture of the compound of Formula I and the compound of Formula II as active ingredient is administered, wherein the mass percentage of the compound of Formula I in the mixture is 1-100%, preferably 90% or more.
